Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 2
2010 1
2011 5
2012 4
2013 3
2014 8
2015 8
2016 6
2017 13
2018 29
2019 21
2020 19
2021 39
2022 17
2023 19
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
The relationship between atherosclerosis and dementia.
Janoutová J, Machaczka O, Kovalová M, Zatloukalová A, Ambroz P, Koutná V, Mrázková E, Bar M, Roubec M, Bártová P, Novobilský R, Sabela M, Kušnierová P, Stejskal D, Faldynová L, Walczysková S, Vališ M, Školoudík L, Šolínová P, Školoudík D, Janout V. Janoutová J, et al. Among authors: valis m. Cent Eur J Public Health. 2024 Mar;32(1):9-15. doi: 10.21101/cejph.a7848. Cent Eur J Public Health. 2024. PMID: 38669152
Intravenous Thrombolysis in Posterior versus Anterior Circulation Stroke: Clinical Outcome Differs Only in Patients with Large Vessel Occlusion.
Halúsková S, Herzig R, Mikulík R, Bělašková S, Reiser M, Jurák L, Václavík D, Bar M, Klečka L, Řepík T, Šigut V, Tomek A, Hlinovský D, Šaňák D, Vyšata O, Vališ M, On Behalf Of The Czech Sits Investigators. Halúsková S, et al. Among authors: valis m. Biomedicines. 2024 Feb 9;12(2):404. doi: 10.3390/biomedicines12020404. Biomedicines. 2024. PMID: 38398006 Free PMC article.
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G; Frexalimab Phase 2 Trial Group. Vermersch P, et al. N Engl J Med. 2024 Feb 15;390(7):589-600. doi: 10.1056/NEJMoa2309439. N Engl J Med. 2024. PMID: 38354138 Clinical Trial.
Corrigendum to "The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease" [Biomed. Pharmacother. 159 (2023) 114223].
Valis M, Dlabkova A, Hort J, Angelucci F, Pejchal J, Kuca K, Pavelek Z, Karasova JZ, Novotny M. Valis M, et al. Biomed Pharmacother. 2023 Sep;165:115226. doi: 10.1016/j.biopha.2023.115226. Epub 2023 Jul 28. Biomed Pharmacother. 2023. PMID: 37516593 Free article. No abstract available.
180 results